PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4-(3-phenylpropyl)pyridine | 218-159-1 | 2057-49-0 | - | - | 1 | - | - | - | - | - | - | Details |
| 4-(3-methylbut-2-enyl)phenol | 686-822-6 | 1200-09-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one | 933-435-8 | 569646-79-3 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(3-Ethoxy-4-hydroxyphenyl)-2-butanone | 810-128-6 | 569646-79-3 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(3-chloropropyl)morpholine | 461-510-0 | 7357-67-7 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(2-methylpropyl)benzyl propyl ether | 826-704-5 | 1631962-93-0 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide | 605-140-1 | 158237-07-1 | - | - | 1 | - | - | - | - | - | - | Details |
| 4-(2-Chlorophenyl)-9,9-diphenyl-9H-fluorene | 812-055-5 | 713127-22-1 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(2-chloroethyl)morpholinium chloride | 222-881-2 | 3647-69-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(2-Chloroethoxy)benzophenone | 690-635-5 | 3439-73-4 | - | - | - | - | 1 | - | - | - | - | Details |